“Better to remain silentand be thought a foolthan to speak...

“Better to remain silentand be thought a foolthan to speak outand remove all doubt.”- Abraham Lincoln

That’s not what I said, today US based investors have no regulated trading platform to invest in RSH. This is the first of multiple events that will lead to a dual NASDAQl/ASX listing if RSH is successful in executing it’s US plans and grow to a significant entity meeting listing conditions.

In that scenario I would much rather have exposure to huge US based investor pool who have a high risk appetite and understand their healthcare system to realise the potential of wheezo in the context of RPM and established reimbursement.

Quote above provided as general advice